dc.creator | Kolata, Gina | en |
dc.creator | Pollack, Andrew | en |
dc.date.accessioned | 2016-01-08T23:11:39Z | en |
dc.date.available | 2016-01-08T23:11:39Z | en |
dc.date.created | 2008-07-06 | en |
dc.date.issued | 2008-07-06 | en |
dc.identifier.bibliographicCitation | New York Times 2008 July 6; p. A1, A16, A17 | en |
dc.identifier.uri | http://worldcatlibraries.org/registry/gateway?version=1.0&url_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&atitle=In+costly+cancer+drug,+hope+and+a+dilemma:+some+pay+up+to+$100,000+a+year+for+Avastin's+arguable+benefits&title=New+York+Times&date=2008-07&au=Kolata,+Gina;+Pollack,+Andrew | en |
dc.identifier.uri | http://hdl.handle.net/10822/956184 | en |
dc.format | News Article | en |
dc.language | en | en |
dc.source | eweb:317848 | en |
dc.subject | Cancer | en |
dc.subject.classification | Social Control of Science and Technology | en |
dc.subject.classification | Allocation of Health Care Resources | en |
dc.subject.classification | Drugs and Drug Industry | en |
dc.subject.classification | Economics of Health Care | en |
dc.subject.classification | Health Care for Particular Diseases or Groups | en |
dc.title | In Costly Cancer Drug, Hope and a Dilemma: Some Pay Up to $100,000 a Year for Avastin's Arguable Benefits | en |
dc.provenance | Citation prepared by the Library and Information Services group of the Kennedy Institute of Ethics, Georgetown University for the ETHXWeb database. | en |
dc.provenance | Citation migrated from OpenText LiveLink Discovery Server database named EWEB hosted by the Bioethics Research Library to the DSpace collection EthxWeb hosted by DigitalGeorgetown. | en |